<DOC>
	<DOCNO>NCT01536223</DOCNO>
	<brief_summary>Locally advanced nasopharyngeal carcinoma patient ( UICC7th stageIII IVb ) receive either cisplatin plus 5-fluorouracil ( PF ) docetaxel plus cisplatin 5-fluorouracil ( TPF ) neoadjuvant chemotherapy concurrent chemoradiation .</brief_summary>
	<brief_title>Efficacy Study Neoadjuvant Chemotherapy With Chemoradiation Therapy Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>For locally advanced nasopharyngeal carcinoma patient ( UICC7th stageIII IVb ) , investigator randomise assign either 3 cycle cisplatin plus 5-fluorouracil plus ( PF ) 3 cycle docetaxel plus cisplatin 5-fluorouracil ( TPF ) neoadjuvant chemotherapy . 21 day cycle . After neoadjuvant chemotherapy , patient receive intensity modulate radiotherapy ( IMRT ) 2 cycle concurrent chemotherapy cisplatin 80mg/m2 .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1 . Patients newly histologically confirm nonkeratinizing carcinoma . 2 . Tumor stag N23 T34N1 ( accord 7th AJCC stag system ) 3 . No evidence distant metastasis ( M0 ) 4 . Performance status : KPS &gt; 70 5 . With normal liver function test ( ALT , AST &lt; 1.5ULN ) 6 . Renal : creatinine clearance &gt; 60ml/min 7 . Without hematopathy , marrow : WBC &gt; 4*109/L , HGB &gt; 80G/L , PLT &gt; 100*109/L . 8 . With controled blood glucose diabetes patient 9 . Written inform consent 1. WHO type I squamous cell carcinoma adenocarcinoma 2 . Age &gt; 70 &lt; 18 3 . With history renal disease 4 . Prior malignancy ( except adequately treat carcinoma insitu cervix basal/squamous cell carcinoma skin0 5 . Previous chemotherapy radiotherapy ( except nonmelanomatous skin cancer outside intend RT treatment volume ) 6 . Patient pregnant lactating . 7 . Peripheral neuropathy 8 . Emotional disturbance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Nasopharyngeal Carcinoma ( NPC )</keyword>
	<keyword>cisplatin 5-fluorouracil ( PF )</keyword>
	<keyword>docetaxel , cisplatin 5-fluorouracil ( TPF )</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
	<keyword>intensity modulate radiotherapy ( IMRT )</keyword>
</DOC>